Menu
Treatment Comparison

Durolane vs Orthovisc

Durolane vs Orthovisc: compare single injection with 3-injection series. Allergy safety, molecular weight, cost, and best fit.

Side-by-Side Comparison

Injection Schedule

Durolane 1 single injection
Orthovisc 3-4 weekly injections

Source

Durolane Non-animal (NASHA technology)
Orthovisc Non-avian (bacterial fermentation)

Bird Allergy Safe

Durolane Yes
Orthovisc Yes

Molecular Weight

Durolane High (cross-linked NASHA)
Orthovisc High (1-2.9 million Da, native)

Cross-linked

Durolane Yes (minimal stabilization)
Orthovisc No

Volume

Durolane 3 mL (single)
Orthovisc 6-8 mL total (2 mL x 3-4)

Manufacturer

Durolane Bioventus
Orthovisc Anika Therapeutics

FDA Approval

Durolane 2015
Orthovisc 2004

Self-Pay Cost

Durolane $900-$1,300
Orthovisc $600-$1,000

Duration

Durolane 6+ months
Orthovisc Up to 6 months

Medicare Coverage

Durolane Yes
Orthovisc Yes

It Depends on Your Situation

Both Durolane and Orthovisc are non-avian products produced via bacterial fermentation, making both safe for patients with avian allergies. Durolane uses NASHA cross-linking technology for a single injection; Orthovisc delivers more total non-cross-linked HA over 3-4 visits at a lower drug cost.

Best for: Durolane for single-injection convenience with NASHA cross-linking; Orthovisc for lower cost and non-cross-linked natural HA delivered in a series.

NASHA Single Shot vs. Natural HA Series

Durolane and Orthovisc are both non-avian hyaluronic acid products produced via bacterial fermentation, making both safe for patients with avian allergies. Where they differ is in formulation and delivery: Durolane uses NASHA (Non-Animal Stabilized Hyaluronic Acid) cross-linking technology and delivers treatment in a single injection, while Orthovisc is non-cross-linked plain HA delivered over 3-4 weekly visits at a lower drug cost.


Quick Comparison Table

FeatureDurolaneOrthovisc
ManufacturerBioventusAnika Therapeutics
SourceBacterial fermentation (NASHA)Bacterial fermentation
Bird allergy safeYesYes
Injections needed13-4 weekly
Volume per injection3 mL2 mL
Total volume3 mL6-8 mL
Cross-linkedYes (stabilized)No (native HA)
Molecular weightHigh (NASHA)High (1-2.9 million Da)
FDA approval20152004
HCPCS CodeJ7318J7324
Duration6+ monthsUp to 6 months
Self-pay cost$900-$1,300$600-$1,000

What Is Durolane?

Durolane uses NASHA (Non-Animal Stabilized Hyaluronic Acid) technology, originally developed by Q-Med in Sweden. The HA is produced through bacterial fermentation and then minimally stabilized to create a gel that persists longer in the joint.

Durolane’s Unique Position

Durolane uses NASHA (Non-Animal Stabilized Hyaluronic Acid) technology, making it one of two non-avian single-injection options (the other being Monovisc). Its distinguishing feature is minimal cross-linking that stabilizes the HA gel to persist longer in the joint. Among single-injection products, Synvisc-One and Gel-One are avian-derived; Durolane and Monovisc are both non-avian.

Key Strengths

NASHA cross-linking technology - Stabilized HA designed for longer joint residence
Potentially longer duration - Some data suggest 6+ months of relief
Single visit - Complete treatment in one appointment

What Is Orthovisc?

Orthovisc contains ultra-pure, non-cross-linked sodium hyaluronate produced by Anika Therapeutics via bacterial fermentation (the same manufacturer as Monovisc). Its molecular weight of 1-2.9 million Daltons is achieved entirely through purification, not chemical modification.

Key Strengths

Natural HA structure - Closest to your body’s own joint fluid
Lower inflammatory risk - Non-cross-linked products have fewer reaction reports
More total HA - 6-8 mL delivered vs. 3 mL
20+ year track record - FDA-approved since 2004

The Allergy Question

Both Are Safe for Patients With Avian Allergies

Both Durolane and Orthovisc are produced via bacterial fermentation with no animal-derived ingredients. Neither requires avian allergy screening.

If you have avian allergies and want a single-injection product, Durolane and Monovisc are both non-avian single-shot options.


Cross-Linked vs. Non-Cross-Linked

PropertyDurolane (Stabilized)Orthovisc (Non-CL)
ProcessingMinimal cross-linkingNo cross-linking
StructureStabilized gelNatural HA chains
Joint residenceLonger (designed to persist)Shorter per dose
Reaction riskLowLowest
Matches native HAPartiallyClosely

Durolane’s NASHA stabilization is described as “minimal” cross-linking designed to make the HA gel persist longer without the higher reaction rates associated with heavily cross-linked products like Synvisc-One.


Cost Comparison

FactorDurolaneOrthovisc
Drug cost (self-pay)$900-$1,300$600-$1,000
Office visit copays13-4
Total with Medicare$100-$200$150-$300
Total self-pay$925-$1,350$675-$1,200

Insight: Orthovisc has a lower drug cost, but the multiple visit copays narrow the gap. With Medicare, the total cost is often similar.


Making Your Decision

Choose Durolane if:

  • You want non-animal-derived HA with NASHA cross-linking technology
  • You prefer single-visit convenience
  • Potentially longer duration appeals to you

Choose Orthovisc if:

  • You prefer non-cross-linked, natural HA
  • You want more total HA volume (6-8 mL vs. 3 mL)
  • You value the longer safety track record (20+ years)
  • Lower drug cost is a priority
  • You like Anika Therapeutics products (same maker as Monovisc)

Frequently Asked Questions

Which product is more effective?

Both provide similar clinical outcomes for knee OA pain relief. No head-to-head trial has shown clear superiority of either product.

Can I try Orthovisc first and switch to Durolane?

Yes. Switching between HA products is safe and may be helpful if one does not provide adequate relief.

Is Durolane really allergy-safe?

Yes. Durolane is produced entirely through bacterial fermentation with no animal-derived components. It has been tested and confirmed safe for patients with avian allergies.

Which is better for repeat treatments?

Both can be repeated every 6 months. Orthovisc’s non-cross-linked formulation may have a theoretical advantage for long-term repeated use due to lower reaction risk, but Durolane’s track record is also good.


The Bottom Line

Durolane is the go-to for patients who want single-injection convenience with NASHA cross-linking technology for longer-lasting relief. Both Durolane and Orthovisc are non-avian and safe for patients with avian allergies.

Orthovisc is the choice for patients who want non-cross-linked, natural HA with proven long-term safety and more total volume delivered at a lower drug cost.

Both are effective, Medicare-covered, non-avian options. Scheduling preference (single visit vs. series) and HA formulation (cross-linked vs. natural) are the main decision factors.

Find HA Injection Providers

Connect with specialists offering Durolane, Orthovisc, and other viscosupplementation options.

Imaging-Guided Medicare Accepted

Used to find providers in your area

Required to submit this form

Your information is secure. See our Privacy Policy and Terms of Service.

Thank You!

We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.

What happens next?

  • 1 We'll verify your insurance coverage
  • 2 Match you with quality providers in your area
  • 3 Contact you to discuss your options

Questions? Browse our guides:

How to Choose a Provider

HA Treatment Comparisons

Stay informed about viscosupplementation options for knee osteoarthritis.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

Still Not Sure?

Take our quick assessment to find which treatment might be right for your specific situation.